Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2735-2737

  Farrell, David J ^a   Sader, Helio S ^a,b   Jones, Ronald N ^a,c  

^a JMI LABORATORIES   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; GRAM NEGATIVE INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; ASIA; EUROPE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; NORTH AMERICA; STENOTROPHOMONAS MALTOPHILIA;

EID: 77952597308     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01774-09     Document Type: Article

References (14)

1. Choquet-Kastylevsky, G., T. Vial, and J. Descotes. 2002. Allergic adverse reactions to sulfonamides. Curr. Allergy Asthma Rep. 2:16-25.
2. CLSI. 2009. M07-A8. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 8th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
3. CLSI. 2009. M100-S19. Performance standards for antimicrobial susceptibility testing. 19th informational supplement Clinical and Laboratory Standards Institute, Wayne, PA.
4. Entenza, J. M., and P. Moreillon. 2009. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int. J. Antimicrob. Agents 34:8.e1-9
5. Falagas, M. E., A. C. Kastoris, E. K. Vouloumanou, P. I. Rafailidis, A. M. Kapaskelis, and G. Dimopoulos. 2009. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol. 4:1103-1109.
6. Fritsche, T. R., H. S. Sader, M. G. Stilwell, M. J. Dowzicky, and R. N. Jones. 2005. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Diagn. Microbiol. Infect. Dis. 52:187-193.
7. Gales, A. C., R. N. Jones, K. R. Forward, J. Linares, H. S. Sader, and J. Verhoef. 2001. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin. Infect. Dis. 32(Suppl. 2):S104-S113.
8. Garrison, M., D. Anderson, D. Campbell, K. Carroll, C. Malone, J. Anderson, R. Hollis, and M. Pfaller. 1996. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40:2859-2864.
9. Insa, R., E. Cercenado, M. J. Goyanes, A. Morente, and E. Bouza. 2007. In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 59:583-585.
10. Nicodemo, A. C., M. R. Araujo, A. S. Ruiz, and A. C. Gales. 2004. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. J. Antimicrob. Chemother. 53: 604-608.
11. Nicodemo, A. C., and J. I. Paez. 2007. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur. J. Clin. Microbiol. Infect. Dis. 26:229-237.
12. Nicolau, D. P. 2009. Management of complicated infections in the era of antimicrobial resistance: the role of tigecycline. Expert Opin. Pharmacother. 10:1213-1222.
13. Petersen, P. J., N. V. Jacobus, W. J. Weiss, P. E. Sum, and R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
14. Sader, H. S., R. N. Jones, M. J. Dowzicky, and T. R. Fritsche. 2005. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn. Microbiol. Infect. Dis. 52:203-208.